Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Tsuda

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|May 15, 2007
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligandsTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Chemmedchem|January 10, 2018
A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate CancerHiromi Ii, Taku Yoshiya, Susumu Nakata, et al.
Blood|March 23, 2017
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndromeHiroshi Shimazu, Shinya Munakata, Yoshihiko Tashiro, et al.
Journal of Medicinal Chemistry|July 11, 2003
Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesiaYoshio Okada, Yuko Tsuda, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motifTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Pharmacology, Biochemistry, and Behavior|June 20, 2006
Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1Yunden Jinsmaa, Ewa Marczak, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|April 30, 2004
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesiaYunden Jinsmaa, Anna Miyazaki, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|December 13, 2005
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonistsTingyou Li, Yoshio Fujita, Kimitaka Shiotani, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 14, 2022
The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive ratsQinyuan Deng, Yutaka Kakizoe, Yasunobu Iwata, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3)Yoshio Fujita, Yuko Tsuda, Takashi Motoyama, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|May 15, 2007
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligandsTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Chemmedchem|January 10, 2018
A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate CancerHiromi Ii, Taku Yoshiya, Susumu Nakata, et al.
Blood|March 23, 2017
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndromeHiroshi Shimazu, Shinya Munakata, Yoshihiko Tashiro, et al.
Journal of Medicinal Chemistry|July 11, 2003
Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesiaYoshio Okada, Yuko Tsuda, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motifTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Pharmacology, Biochemistry, and Behavior|June 20, 2006
Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1Yunden Jinsmaa, Ewa Marczak, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|April 30, 2004
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesiaYunden Jinsmaa, Anna Miyazaki, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|December 13, 2005
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonistsTingyou Li, Yoshio Fujita, Kimitaka Shiotani, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 14, 2022
The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive ratsQinyuan Deng, Yutaka Kakizoe, Yasunobu Iwata, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3)Yoshio Fujita, Yuko Tsuda, Takashi Motoyama, et al.
Pageof 9